# Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer

> **NCT00782041** · PHASE2 · TERMINATED · sponsor: **Sanofi** · enrollment: 11 (actual)

## Conditions studied

- Uterine Neoplasms

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** 5-FluoroUracil
- **DRUG:** Folinic acid

## Key facts

- **NCT ID:** NCT00782041
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-01
- **Primary completion:** 2003-08
- **Final completion:** —
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** protocol violation
- **Last updated:** 2009-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00782041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00782041, "Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00782041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*